Intradermal needling combined with heat-sensitive moxibustion for moderate to severe cancer pain.
10.13703/j.0255-2930.20200615-k0002
- Author:
Jin-Feng JI
1
;
Xiao-Xia GE
2
;
Chun-Ming XU
1
;
Yang JIANG
3
;
Jun-Hong GU
2
;
Guo-Hua WEI
1
;
Ji-Shu GU
1
;
Yong-Jie SHI
1
;
Xue-Jiao NI
1
Author Information
1. Department of Oncology of Integrated Chinese and Western Medicine, Jiangsu Tumor Hospital Affiliated to Nantong University, Nantong 226001, China.
2. Department of Oncology, Jiangsu Tumor Hospital Affiliated to Nantong University, Nantong 226001, China.
3. Department of Acupuncture and Moxibustion, Jiangsu Tumor Hospital Affiliated to Nantong University, Nantong 226001, China.
- Publication Type:Randomized Controlled Trial
- Keywords:
cancer pain;
heat-sensitive moxibustion;
intradermal needling;
three-step analgesic method
- MeSH:
Acupuncture Points;
Cancer Pain/therapy*;
Hot Temperature;
Humans;
Moxibustion;
Neoplasms/therapy*;
Pain;
Quality of Life;
Treatment Outcome
- From:
Chinese Acupuncture & Moxibustion
2021;41(7):725-729
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the effect of intradermal needling combined with heat-sensitive moxibustion for moderate to severe cancer pain.
METHODS:A total of 60 patients with moderate to severe cancer pain were randomly divided into an observation group and a control group，30 cases in each one. In the control group，opioids were taken to relief pain according to the three-step analgesic method of World Health Organization. On the base of the treatment as the control group, intradermal needling combined with heat-sensitive moxibustion were applied at Neiguan (PC 6), Hegu (LI 4), Zusanli (ST 36), Taichong (LR 3), etc. in the observation group, 14 days of treatment were required. The equivalent morphine consumption at the first day and whole course, the scores of cancer quality of life questionnaire-C30 (QLQ-C30) and Hamilton anxiety scale before and after treatment, and the adverse reaction rate were compared in the two groups. The total analgesic effective rate was evaluated.
RESULTS:The total analgesic effective rate was 93.3% (28/30) in the observation group, higher than 73.3% (22/30) in the control group (
CONCLUSION:Intradermal needling combined with heat-sensitive moxibustion can reduce the dose of opioids, improve the quality of life, relief the anxiety in patients with moderate to severe cancer pain, and reduce the incidence of common adverse reaction of opioids.
